Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

Ann Hematol. 2020 May;99(5):1137-1139. doi: 10.1007/s00277-020-03972-0. Epub 2020 Mar 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Combined Modality Therapy / adverse effects
  • Combined Modality Therapy / methods
  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / therapeutic use
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host
  • Risk Factors
  • Transplantation, Haploidentical / adverse effects*
  • Virus Activation* / immunology
  • Virus Diseases / diagnosis
  • Virus Diseases / etiology*

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide